Amneal Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2018 to Q3 2025.
  • Amneal Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 314M shares, a 1.46% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 309M shares, a 75.4% increase from 2023.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 176M shares, a 16.7% increase from 2022.
  • Amneal Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 151M shares, a 1.36% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Amneal Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 314M +4.52M +1.46% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 314M +4.62M +1.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 311M +3.78M +1.23% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 309M +133M +75.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 310M +155M +101% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 309M +155M +101% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 307M +155M +102% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 176M +25.2M +16.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 154M +2.83M +1.87% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 154M +2.75M +1.82% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 152M +2.22M +1.48% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 151M +2.02M +1.36% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 151M +2.1M +1.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 151M +2M +1.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 150M +1.88M +1.27% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 149M +1.48M +1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 149M +1.73M +1.17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 149M +1.6M +1.09% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 148M +833K +0.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 147M +15.3M +11.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-03
Q3 2020 148M +16.8M +12.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 147M +19.4M +15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 147M +19.5M +15.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 132M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 131M +3.48M +2.74% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 128M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 128M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 127M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07

Amneal Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 309M +133M +75.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 176M +25.2M +16.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 151M +2.02M +1.36% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 149M +1.48M +1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 147M +15.3M +11.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 132M +4.85M +3.81% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 127M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.